https://doi.org/10.18093/0869-0189-2012-0-4-56-61
About the Authors
T. N. Bilichenko
ФГУ "НИИ пульмонологии" ФМБА России
Russian Federation
Russian Federation
L. S. Popova
ФБЛПУ "Поликлиника Федеральной налоговой службы"
Russian Federation
Russian Federation
A. G. Bikbulatova
ФБЛПУ "Поликлиника Федеральной налоговой службы"
Russian Federation
Russian Federation
L. V. Gritsenko
ФБЛПУ "Поликлиника Федеральной налоговой службы"
Russian Federation
Russian Federation
N. K. Trofimchuk
ФБЛПУ "Поликлиника Федеральной налоговой службы"
Russian Federation
Russian Federation
T. F. Ushakova
ФБЛПУ "Поликлиника Федеральной налоговой службы"
Russian Federation
Russian Federation
L. P. Rudakova
ФБЛПУ "Поликлиника Федеральной налоговой службы"
Russian Federation
Russian Federation
References
1. Human infection with influenza A (H1N1) virus: clinical observations from Mexico and other affected countries. WHO. Wkly Epidemiol. Rec. 2009; 84 (21): 185–196. http://www.who.int/wer
2. WHO. Clinical management of human infection with new influenza A virus: ivitial guidance. 21 May 2009. 1–6.
3. CDC H1N1 Flu updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 seasons. http://www.cdc.gov/flu/
Review
For citations:
Bilichenko T.N., Popova L.S., Bikbulatova A.G., Gritsenko L.V., Trofimchuk N.K., Ushakova T.F., Rudakova L.P. . PULMONOLOGIYA. 2012;(4):56-61. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-4-56-61
Views:
943
Email this article 